Rip Ballou | Vice President And Head Of Global Vaccines, Research And Development Center

Rip Ballou, Vice President And Head Of Global Vaccines, Research And Development Center, GSK

W. Ripley Ballou, MD is Vice President and Head, Global Vaccines US R&D Center located in Rockville, Maryland USA. Previously he served as VP & Head Clinical Research & Translational Science for GSK Vaccines in Rixensart, Belgium. Prior to this he served as Deputy Director for Vaccines, Infectious Diseases Development, Global Health at the Bill & Melinda Gates Foundation. Dr. Ballou is an expert in vaccine development and has worked in this field for more than 30 years. Trained in Internal Medicine and Infectious Diseases, he began his work on vaccines at the Walter Reed Army Institute of Research where he led the team that with GlaxoSmithKline co-developed RTS,S, the world’s most advanced malaria vaccine. Dr. Ballou has numerous publications in the field of vaccine development and infectious diseases.


April 15 Plenary Congress Day 1 @ 09:45

How can we be better prepared for disease X?

  • What kind of regulatory and political support can we expect?
  • Prevention and pre-prepared efforts to ensure our current and future safety
  • Vaccine development and innovation including the current landscape, existing challenges, and drivers and levers to incentivize development

April 16 Day 2 - 10 Co-conferences @ 14:55

The “Big Four” explore how they partner and what they are looking for in a partner

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071